Abstract 1422: Neuropilin-2, a potential target against neuroendocrine like therapy resistant prostate cancer
Abstract
Background: Prostate cancer (PCa) patient management is becoming increasingly challenging owing to the emergence of advanced therapy-resistant PCa. Published reports from our laboratory demonstrated that neuropilin-2 (NRP2), a non-tyrosine kinase transmembrane receptor, is associated with therapy resistance in aggressive PCa. Such advanced PCa is often associated with diverse genetic changes that complicate the therapeutic interventions. One...
Paper Details
Title
Abstract 1422: Neuropilin-2, a potential target against neuroendocrine like therapy resistant prostate cancer
Published Date
Jul 1, 2021
Journal
Volume
81
Issue
13_Supplement
Pages
1422 - 1422
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History